Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Rosetta Inpharmatics

1996 FOUNDED
M&A STATUS
101-200 EMPLOYEES
M&A LATEST DEAL TYPE
3 FINANCING ROUNDS
Description

Provider of an informational genomics platform. The company's integrated platform includes the design and analysis of proprietary DNA microarrays, a powerful, flexible informatics system and advanced molecular biology techniques to support gene expression profiling programs.

Website
Formerly Known As
Rosetta Biosystems
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Other Healthcare Technology Systems
Acquirer
Primary Office
  • 12040-115th Avenue
  • North East
  • Kirkland, WA 98034
  • United States

Rosetta Inpharmatics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Rosetta Inpharmatics‘s full profile, request access.

Request full access to PitchBook

Rosetta Inpharmatics Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Rosetta Inpharmatics‘s full profile, request access.

Request full access to PitchBook

Rosetta Inpharmatics Executive Team (6)

Name Title Board
Seat
Contact
Info
Jasper Rine Co-Founder
Stephen Friend Co-Founder
Leroy Hood Ph.D Co-Founder

3 Former Executives

You’re viewing 3 of 6 executives. Get the full list »